- Home
- COEP vs ORIS Comparison
COEP vs ORIS Comparison
Compare COEP & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- ORIS
- Stock Information
- Founded
- COEP 2017
- ORIS 2014
- Country
- COEP United States
- ORIS China
- Employees
- COEP N/A
- ORIS N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- ORIS Farming/Seeds/Milling
- Sector
- COEP Health Care
- ORIS Consumer Staples
- Exchange
- COEP Nasdaq
- ORIS Nasdaq
- Market Cap
- COEP 27.4M
- ORIS 12.1M
- IPO Year
- COEP N/A
- ORIS 2024
- Fundamental
- Price
- COEP $9.47
- ORIS $0.65
- Analyst Decision
- COEP
- ORIS
- Analyst Count
- COEP 0
- ORIS 0
- Target Price
- COEP N/A
- ORIS N/A
- AVG Volume (30 Days)
- COEP 37.4K
- ORIS 195.7K
- Earning Date
- COEP 08-15-2025
- ORIS 02-21-2025
- Dividend Yield
- COEP N/A
- ORIS N/A
- EPS Growth
- COEP N/A
- ORIS N/A
- EPS
- COEP N/A
- ORIS 0.17
- Revenue
- COEP $62,874.00
- ORIS $15,014,000.00
- Revenue This Year
- COEP N/A
- ORIS N/A
- Revenue Next Year
- COEP N/A
- ORIS N/A
- P/E Ratio
- COEP N/A
- ORIS $3.79
- Revenue Growth
- COEP N/A
- ORIS N/A
- 52 Week Low
- COEP $2.31
- ORIS $0.50
- 52 Week High
- COEP $13.70
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- COEP 62.24
- ORIS N/A
- Support Level
- COEP $7.25
- ORIS N/A
- Resistance Level
- COEP $9.90
- ORIS N/A
- Average True Range (ATR)
- COEP 0.63
- ORIS 0.00
- MACD
- COEP 0.26
- ORIS 0.00
- Stochastic Oscillator
- COEP 85.62
- ORIS 0.00
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).